Device type · QFV
Implantable Pulse Generator
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QFV
Cardiovascular
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
89
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Implantable Pulse Generator
- Product code
- QFV
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for QFV
Latest FDA decisions
- OPTIMIZER Smart SystemBreakthroughPMA
P180036 · Decided Mar 21, 2019 · 197 days after receipt
Device type: Implantable pulse generator (QFV) · Cardiology
Reports received
89
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
16
18% of reports
Injury reports
73
82% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 1 | 0 | 0 |
| Jan 24 | 3 | 1 | 1 | 0 |
| Feb 24 | 4 | 1 | 1 | 0 |
| Mar 24 | 3 | 3 | 0 | 0 |
| Apr 24 | 2 | 2 | 0 | 0 |
| May 24 | 1 | 1 | 0 | 0 |
| Jun 24 | 1 | 0 | 1 | 0 |
| Jul 24 | 1 | 1 | 0 | 0 |
| Aug 24 | 2 | 4 | 0 | 0 |
| Sep 24 | 2 | 1 | 0 | 0 |
| Oct 24 | 0 | 4 | 0 | 0 |
| Nov 24 | 1 | 1 | 0 | 0 |
| Dec 24 | 1 | 2 | 0 | 0 |
| Jan 25 | 0 | 2 | 0 | 0 |
| Feb 25 | 0 | 1 | 0 | 0 |
| Mar 25 | 0 | 3 | 0 | 0 |
| Apr 25 | 1 | 1 | 0 | 0 |
| May 25 | 0 | 2 | 0 | 0 |
| Jun 25 | 0 | 2 | 0 | 0 |
| Jul 25 | 0 | 2 | 0 | 0 |
| Aug 25 | 1 | 2 | 0 | 0 |
| Sep 25 | 0 | 3 | 0 | 0 |
| Oct 25 | 3 | 0 | 0 | 0 |
| Nov 25 | 2 | 4 | 0 | 0 |
| Dec 25 | 2 | 0 | 0 | 0 |
| Jan 26 | 0 | 5 | 0 | 0 |
| Feb 26 | 1 | 4 | 0 | 0 |
| Mar 26 | 0 | 4 | 0 | 0 |
| Apr 26 | 2 | 6 | 0 | 0 |
| May 26 | 3 | 2 | 0 | 0 |
| Jun 26 | 2 | 1 | 0 | 0 |
| Jul 26 | 1 | 2 | 0 | 0 |
| Aug 26 | 1 | 39 | 0 | 0 |
| Sep 26 | 2 | 3 | 0 | 0 |
| Oct 26 | 0 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem37
- Misassembly by Users19
- Failure to Charge12
- Charging Problem2
- Device Sensing Problem2
- High impedance2
- Under-Sensing2
- Aborted Charge1
- Delayed Charge Time1
- Detachment of Device or Device Component1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions41
- Heart Failure/Congestive Heart Failure6
- Unspecified Infection5
- Cardiovascular Dysfunction/Insufficiency4
- Discomfort3
- Twiddlers Syndrome3
- Device Overstimulation of Tissue2
- Insufficient Information2
- Medical device site infection2
- Pericardial Effusion2
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- OPTIMIZER model CCM X11 implantable pulse generator (IPG) devices - Smart Mini and LiteOpen, Classified
Z-1173-2024 · Started Jan 5, 2024 · Posted by FDA Feb 22, 2024
Reason given: OPTIMIZER devices may cease to deliver CCM therapy if the device incorrectly detects a charging error. This may cause patients to experience heart failure symptoms similar to before implantation of the device.
Cause as FDA categorized it: Software design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.